SABBA STEPHEN L sold 6.0% of their position (2.15K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $544.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/18/2026ACC: 0001104659-26-075456
-2.15K
Net shares
Net seller
$544.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.15K acquired · 4.29K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.15K
Price / share
$66.13
Trade value
$141.85K
% of position
6.4%
6/16/2026
33.63K→35.77K
Common Stock
Direct
Shares
−2.15K
Price / share
$254.00
Trade value
$544.83K
% of position
6.0%
6/16/2026
35.77K→33.63K
Total
Net shares
+0.00
Net value
-$402.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/16/2026 | M · Option Exercise | +2.15K | $66.13 | $141.85K | 6.4% | 33.63K | 35.77K |
| Common Stock Direct | 6/16/2026 | S · Sale | −2.15K | $254.00 | $544.83K | 6.0% | 35.77K | 33.63K |
| Total | +0.00 | -$402.98K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
2.15K shares
Shares
−2.15K
Strike price
66.13
Held after
0.00
Exercisable
—
6/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock2.15K shares | 6/16/2026 | M · Option Exercise | −2.15K | 66.13 | — | 0.00 |